Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT02738775 · COMPLETED
Trial details
- NCT number
- NCT02738775
- Sponsor
- TG Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-27
- Primary completion
- 2017-09-27
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.